Fertility preservation in women with ovarian endometriosis

In: Médecine de la Reproduction, Gynécologie Endocrinologie, Vol. 16, no.4, p. 259-268 (2014) · 2014 · vol. 16(4) , pp. 259–268 · doi:10.1684/mte.2014.0536 · W1709457282
article OA: green CC0 ⤵ 1 in-corpus citation
AI-generated summary by claude@2026-06, 2026-06-07

This manuscript focuses on fertility preservation strategies for women diagnosed with severe ovarian endometriosis, a condition causing pain and infertility.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-07 · read from full text

This manuscript focuses on fertility preservation strategies in women with severe ovarian endometriosis, framing endometriosis as a common benign gynecologic disease that contributes to pelvic pain and infertility in over 35% of women of reproductive age. It describes an overall therapeutic aim that includes preserving and improving fertility, alongside reducing pain and delaying disease recurrence, while noting that complete resolution of endometriosis is not possible. The paper’s main limitation is that it is a narrative-focused overview centered on severe endometriosis rather than reporting new original study data. This paper is centrally about endometriosis — specifically, fertility preservation in women with ovarian endometriosis (with emphasis on severe disease).

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Endometriosis is one of the most frequently encountered benign diseases in gynecology. It is the cause of pelvic pain (dysmenorrhea, dyspareunia) and infertility in more than 35% of women of reproductive age [1]. Complete resolution of endometriosis is not possible, but therapy has essentially three main objectives: to preserve and improve fertility; to reduce pain; and to delay recurrence for as long as possible. The aim of this manuscript is to focus on fertility preservation in women with severe endometriosis.
Full text 1,149 characters · extracted from oa-html · click to expand
Fertility preservation in women with ovarian endometriosis (2014) Medecine Therapeutique - Endocrinologie — Vol. 16, n° 4, p. 259-268 (2014) (2014) Medecine Therapeutique - Endocrinologie — Vol. 16, n° 4, p. 259-268 (2014) Open Access - Adobe PDF - 6.25 MB - Authors - Author Donnez, Jacques UCLouvain - Author Donnez, Olivier UCLouvain - Author - Abstract - Endometriosis is one of the most frequently encountered benign diseases in gynecology. It is the cause of pelvic pain (dysmenorrhea, dyspareunia) and infertility in more than 35% of women of reproductive age [1]. Complete resolution of endometriosis is not possible, but therapy has essentially three main objectives: to preserve and improve fertility; to reduce pain; and to delay recurrence for as long as possible. The aim of this manuscript is to focus on fertility preservation in women with severe endometriosis. - Affiliations - APA - Chicago - FWB Donnez, J., Donnez, O., & Dolmans, M.-M. (2014). Fertility preservation in women with ovarian endometriosis. Medecine Therapeutique - Endocrinologie, 16(4), 259-268. https://doi.org/10.1684/mte.2014.0536 (Original work published 2014)

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisdysmenorrheadyspareuniainfertility

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK